HIPAA-compliant · Same-day admissions available
Robin Campbell, LMFT, PHD Benzodiazepine withdrawal can catch many patients off guard, especially after long term benzodiazepine use that began with a prescription for anxiety or sleep.
Maverick
Clinical Editorial Team
Benzodiazepine withdrawal can catch many patients off guard, especially after long term benzodiazepine use that began with a prescription for anxiety or sleep. Different benzodiazepines can lead to different withdrawal experiences because their half life, strength, and effects on the body are not the same. Medications like alprazolam, Xanax, and diazepam can lead to physiologic dependence over time, and withdrawal severity often rises with rapid discontinuation, a large dosage reduction, or high doses above typical therapeutic ranges.
The process can look very different from person to person based on the initial dose, daily dose, duration of use, and the specific drug involved. An estimated 50 to 80 percent of people who take benzodiazepines continually for a few weeks or longer may experience withdrawal symptoms when reducing the dose. Some people develop benzodiazepine withdrawal syndrome with muscle twitches, clouded thinking, and other adverse effects, while others face protracted withdrawal symptoms that can last for several months.
Benzodiazepine dependence happens when the body and brain adjust to the drug over time. These medications are often used for anxiety, panic, sleep problems, seizures, or muscle spasms, but repeated use can make it harder for the nervous system to function normally without them. A person may begin to rely on benzodiazepines to feel calm, sleep, or get through daily life. Taking benzodiazepines over a long period can lead to dependence, making it difficult to stop without experiencing withdrawal symptoms. In addiction recovery, early treatment matters because dependence can grow into a serious problem that affects physical health, mental health, and long-term stability. Withdrawal can also impact cognitive abilities such as memory and concentration, and some individuals may experience cognitive deficits that persist for months or even years after stopping benzodiazepines.
Benzodiazepine withdrawal starts when a person lowers the dose or stops taking the drug after the body has adapted to it. Since these medications slow activity in the central nervous system, withdrawal can cause the nervous system to become overactive and trigger symptoms like anxiety, insomnia, sweating, tremors, nausea, and panic.
Symptoms can range from mild to severe based on the drug, dose, length of use, and other substances involved. A slow supervised taper, medical support, and therapy can help reduce risk, manage symptoms safely, and support long-term recovery through residential or outpatient treatment. Alternative strategies, such as gradual dose reductions, patient education, and psychological support, are key to safely managing benzodiazepine withdrawal.
Benzodiazepine withdrawal can be dangerous because the brain and body may react strongly when the drug is reduced too fast or stopped suddenly. Since benzodiazepines slow activity in the central nervous system, withdrawal can cause the system to rebound in a way that creates intense physical and emotional symptoms. Some people face serious risks such as seizures, severe panic, confusion, heart-related symptoms, and extreme agitation. Abrupt withdrawal from benzodiazepines can lead to grand mal seizures, psychosis, delirium, rapid heartbeat, and thoughts of self-harm, including suicidal thoughts. Severe benzodiazepine withdrawal symptoms may also include hallucinations and delirium. A supervised taper lowers these risks and gives people a safer path into recovery, especially when mental health issues or other substance use are also present.
Benzodiazepines increase the effect of gamma aminobutyric acid, or GABA, which is a chemical messenger that slows brain activity. This can create a calming effect, reduce anxiety, relax muscles, and help with sleep, but it can also slow reaction time, affect memory, and reduce alertness.
With repeated use, the brain starts to adjust to that slowing effect. Over time, the body may rely on the drug to feel normal, which can lead to tolerance, dependence, and withdrawal when use is reduced or stopped.
Clinical pharmacology research has identified medications, such as flumazenil, that may be used during medical detoxification to help manage benzodiazepine withdrawal symptoms safely.
Benzodiazepine misuse and dependence remain a serious public health concern, especially among people who use these medications for long periods or combine them with other substances. Misuse can include taking higher doses than prescribed, using someone else’s medication, or mixing benzodiazepines with opioids or alcohol. Dependence can develop even in people who started with a valid prescription. This is one reason treatment providers continue to watch benzodiazepine use closely and why supervised tapering and addiction treatment remain important parts of recovery care.
Short-Term:
Long-Term:
Stopping benzodiazepines too fast can cause the nervous system to become overactive very quickly. This can lead to severe anxiety, panic attacks, insomnia, and physical distress that may feel overwhelming and hard to control.
In more serious cases, rapid withdrawal can lead to seizures, confusion, hallucinations, or dangerous changes in heart rate and blood pressure. These risks make it unsafe to stop without medical support, especially for people who have used benzodiazepines for a long time or at higher doses.
A slow supervised taper gives the body time to adjust as the dose is reduced step by step. A slow tapering schedule is recommended, with reductions of 5 to 10% every 2 to 4 weeks, to minimize withdrawal symptoms. This method helps lower the intensity of withdrawal symptoms and reduces the risk of severe complications like seizures or extreme distress. Doctors design taper plans based on the specific benzodiazepine, dosage, length of use, and the person’s mental and physical health. The British National Formulary suggests that it is better to withdraw too slowly than too quickly from benzodiazepines. Switching to a longer acting benzodiazepine, such as diazepam, is often recommended to smooth the tapering process and reduce withdrawal severity. In a structured treatment setting, providers monitor symptoms, adjust the pace as needed, and support the person through therapy and daily care to improve safety and outcomes. For patients taking high doses of benzodiazepines, initial reductions can be 25% to 30%, followed by smaller reductions of 5% to 10% as tolerated. Primary care providers often play a crucial role in guiding safe tapering strategies and supporting patients throughout the process. Withdrawing benzodiazepines in general practice requires careful management because these CNS drugs can cause serious withdrawal symptoms if reduced too quickly.
Benzodiazepine withdrawal can last from a few days to several weeks depending on the drug and how long it was used. Withdrawal symptoms may begin within 10-12 hours for short-acting benzodiazepines and may take a few days for longer-acting ones to appear. The withdrawal process typically occurs in three phases: Early Withdrawal, Acute Withdrawal, and Protracted Withdrawal, with timelines varying based on the drug’s half-life. Withdrawal symptoms can also fluctuate in intensity, with periods of relief known as ‘windows’ and periods of increased symptoms known as ‘waves’. Short-acting benzodiazepines may cause symptoms sooner, while long-acting ones may delay onset.
Some people continue to experience symptoms beyond the initial phase. This can depend on overall health, mental health conditions, and whether the taper was gradual. Using longer acting benzodiazepines during tapering can help delay the onset of withdrawal symptoms and make the process smoother.
Post acute withdrawal can continue after the initial detox phase ends. Protracted withdrawal syndrome can extend several months or even years after stopping benzodiazepine use, affecting about 10% of individuals. About 10% of people who abuse benzodiazepines may still feel withdrawal symptoms years after they have stopped taking the drugs. Symptoms may include anxiety, sleep problems, mood changes, and difficulty focusing. These symptoms can come and go over time and may last for weeks or months. Ongoing therapy, structure, and support can help manage these challenges and reduce relapse risk.
Benzodiazepines are often used with other substances to increase or balance effects. Many people combine them with alcohol, opioids such as heroin, oxycodone, or fentanyl, or stimulants like cocaine and methamphetamine.
Using multiple substances at once increases the risk of overdose, severe dependence, and more complex withdrawal. Treatment often needs to address all substances involved to support safe and lasting recovery.
Benzodiazepine use often connects to underlying mental health conditions. Common co-occurring issues include anxiety disorders, major depression, post traumatic stress disorder, panic disorder, and chronic insomnia. Some individuals may also struggle with bipolar disorder, obsessive compulsive disorder, or long-term stress and emotional dysregulation. Treating these conditions alongside substance use is key to improving stability and reducing relapse risk.
Dual diagnosis treatment focuses on both substance use and mental health at the same time. This approach helps reduce symptoms that often drive continued benzodiazepine use. In structured programs, therapy, medication management, and daily support work together to stabilize both areas. This type of care can improve long-term outcomes and help people build healthier coping patterns.
Medical detox provides a controlled setting where benzodiazepine withdrawal is managed safely under close supervision. Doctors assess the medication used, dose, length of use, and mental and physical health, then use a gradual taper to lower the dose over time and reduce the risk of severe withdrawal symptoms. Staff monitor symptoms, sleep, and vital signs throughout detox. The British Journal of Clinical Pharmacology highlights the effectiveness of certain medications, such as flumazenil, in easing withdrawal symptoms during medical detoxification. Many people move into residential or outpatient treatment after stabilization to continue recovery work.
A person should seek help if they have trouble stopping benzodiazepines or feel withdrawal symptoms when reducing use. Ongoing anxiety, panic, or reliance on the drug can also be warning signs. Early treatment can reduce risk and make withdrawal safer. Professional care can guide the taper process and support long-term recovery.
Many insurance plans help cover benzodiazepine withdrawal treatment, including detox, residential care, and outpatient programs. Coverage levels depend on the provider, plan, and type of treatment needed. It is important to verify benefits early to understand costs and avoid delays. Treatment centers often have admissions teams that can help check coverage and discuss payment options.
Benzodiazepine withdrawal can be potentially dangerous, especially for long term users or patients who try stopping too quickly. A slow taper and careful monitoring can help lower withdrawal severity, reduce risk, and make the process safer.
For many patients, recovery also means treating substance use disorder, mental health symptoms, and other causes tied to long term treatment. With the right support, patients can move forward with more stability and a better path to lasting recovery.
At New Hope Healthcare, as an in-network provider we work with most insurance plans, such as:
If you or a loved one are struggling with mental health challenges or substance abuse, seeking treatment and emotional support is crucial. Consulting a doctor can provide the necessary support and guidance for your teen. Reach out to New Hope Healthcare today. Our team of compassionate professionals is here to support your journey towards lasting well-being. Effective medication management is a crucial part of the treatment process to ensure safety and success. Give us a call at 866-799-0806.
Visit SAMHSA for more information.
The safest way to stop benzodiazepines is through a slow taper under medical supervision. This lowers the risk of severe withdrawal symptoms and helps the body adjust over time.
Benzodiazepine withdrawal can last days, weeks, or longer depending on the drug, dose, and length of use. Some people also deal with ongoing symptoms that take more time to improve.
Yes, benzodiazepine withdrawal can be dangerous, especially if someone stops suddenly. Risks can include severe anxiety, panic, seizures, and other serious symptoms that need medical care.
Common symptoms include anxiety, insomnia, irritability, sweating, tremors, nausea, and trouble concentrating. Some people may also have panic attacks or more severe complications.
A taper helps reduce shock to the nervous system and lowers the risk of dangerous withdrawal effects. It also gives doctors time to adjust the plan based on symptoms.
Someone should get treatment if they have regular benzodiazepine use, withdrawal symptoms, or trouble stopping on their own. Professional support can help make detox and ongoing recovery safer.
In This Article
Tags
Clinically Reviewed by: Dr. Robin Campbell, LMFT, PHD Many parents are concerned about youth vaping, especially as vaping devices, e cigarettes, marijuana products, and other tobacco products become more common among high school students and other young people.
Clinically Reviewed by: Dr. Robin Campbell, LMFT, PHD Alcohol use disorder affects people from all backgrounds and can range from risky drinking patterns to severe alcohol use disorder.
Clinically Reviewed by: Dr. Robin Campbell, LMFT, PHD Teen vaping has become a growing concern for families across Knox County. Many parents worry about nicotine addiction, THC use, e cigarettes, and the long-term effects of tobacco and nicotine exposure on adolescents and young adults.
Clinically Reviewed by: Dr. Robin Campbell, LMFT, PHD Opioid addiction can affect health, work, family, and daily life. Many patients who start with prescription pain relievers may develop substance use disorders that are hard to stop without support.
Clinically Reviewed by: Dr. Robin Campbell, LMFT, PHD A benzo taper can be an important part of recovery for people who have become dependent on Xanax, Klonopin, Ativan, or other benzodiazepines.
Clinically Reviewed by: Dr. Robin Campbell, LMFT, PHD Xylazine, a veterinary tranquilizer, is increasingly being found alongside fentanyl and other drugs in the illicit drug market, creating new challenges during the ongoing overdose crisis.
New Hope Health offers client-centered services. Reach out for a confidential consultation and see exactly how we'd apply these strategies to your facility.
